AVITA Medical (RCEL) Capital Expenditures (QoQ) (2019 - 2025)
AVITA Medical (RCEL) Capital Expenditures (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | AVITA Medical | 309.50 Mn | 298.36 Mn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -54.89% |
| Sep 30, 2025 | 221.92% |
| Jun 30, 2025 | -66.97% |
| Mar 31, 2025 | 175.68% |
| Dec 31, 2024 | -549.23% |
| Sep 30, 2024 | 108.07% |
| Jun 30, 2024 | -170.18% |
| Mar 31, 2024 | 287.50% |
| Dec 31, 2023 | -41.04% |
| Sep 30, 2023 | -13.89% |
| Jun 30, 2023 | 6,477,577.78% |
| Mar 31, 2023 | 100.00% |
| Sep 30, 2021 | 3,715.00% |
| Jun 30, 2021 | -96.21% |
| Mar 31, 2021 | 1,010.34% |
| Dec 31, 2020 | -127.75% |
| Mar 31, 2020 | 97.22% |
| Dec 31, 2019 | -1,100.00% |